CLC number:
On-line Access: 2024-08-27
Received: 2023-10-17
Revision Accepted: 2024-05-08
Crosschecked: 2022-04-22
Cited: 0
Clicked: 1368
Citations: Bibtex RefMan EndNote GB/T7714
Xuan LIU, Xueqing ZHOU, Xuwei SHANG, Li WANG, Yi LI, Hong YUAN, Fuqiang HU. Erratum to: Inhibition of chemotherapy-related breast tumor EMT by application of redox-sensitive siRNA delivery system CSO-ss-SA/siRNA along with doxorubicin treatment[J]. Journal of Zhejiang University Science B, 2022, 23(2): 171-172.
@article{title="Erratum to: Inhibition of chemotherapy-related breast tumor EMT by application of redox-sensitive siRNA delivery system CSO-ss-SA/siRNA along with doxorubicin treatment",
author="Xuan LIU, Xueqing ZHOU, Xuwei SHANG, Li WANG, Yi LI, Hong YUAN, Fuqiang HU",
journal="Journal of Zhejiang University Science B",
volume="23",
number="2",
pages="171-172",
year="2022",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B19e0468"
}
%0 Journal Article
%T Erratum to: Inhibition of chemotherapy-related breast tumor EMT by application of redox-sensitive siRNA delivery system CSO-ss-SA/siRNA along with doxorubicin treatment
%A Xuan LIU
%A Xueqing ZHOU
%A Xuwei SHANG
%A Li WANG
%A Yi LI
%A Hong YUAN
%A Fuqiang HU
%J Journal of Zhejiang University SCIENCE B
%V 23
%N 2
%P 171-172
%@ 1673-1581
%D 2022
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B19e0468
TY - JOUR
T1 - Erratum to: Inhibition of chemotherapy-related breast tumor EMT by application of redox-sensitive siRNA delivery system CSO-ss-SA/siRNA along with doxorubicin treatment
A1 - Xuan LIU
A1 - Xueqing ZHOU
A1 - Xuwei SHANG
A1 - Li WANG
A1 - Yi LI
A1 - Hong YUAN
A1 - Fuqiang HU
J0 - Journal of Zhejiang University Science B
VL - 23
IS - 2
SP - 171
EP - 172
%@ 1673-1581
Y1 - 2022
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B19e0468
Abstract: The online version of the original article can be found at
[1]LiuX, ZhouXQ, ShangXW, et al., 2020. Inhibition of chemotherapy-related breast tumor EMT by application of redox-sensitive siRNA delivery system CSO-ss-SA/siRNA along with doxorubicin treatment. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 21(3):218-233.http://doi.org/10.1631/jzus.B1900468
Open peer comments: Debate/Discuss/Question/Opinion
<1>